NCT02869568 Institut Paoli Calmettes Ovarian Cancer Database
| NCT ID | NCT02869568 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Institut Paoli-Calmettes |
| Condition | Ovarian Neoplasms |
| Study Type | OBSERVATIONAL |
| Enrollment | 6,000 participants |
| Start Date | 2000-01 |
| Primary Completion | 2030-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 6,000 participants in total. It began in 2000-01 with a primary completion date of 2030-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Database of Institut Paoli-Calmettes patients diagnosed with ovarian cancer
Eligibility Criteria
Inclusion Criteria: * Patient with a diagnosis of ovarian cancer Exclusion Criteria: * Diagnosis of fallopian tube cancer
Contact & Investigator
Frequently Asked Questions
Who can join the NCT02869568 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 95 Years, studying Ovarian Neoplasms. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT02869568 currently recruiting?
Yes, NCT02869568 is actively recruiting participants. Contact the research team at drci.up@ipc.unicancer.fr for enrollment information.
Where is the NCT02869568 trial being conducted?
This trial is being conducted at Marseille, France.
Who is sponsoring the NCT02869568 clinical trial?
NCT02869568 is sponsored by Institut Paoli-Calmettes. The trial plans to enroll 6,000 participants.